|
|
||||||||
a Département de Cardiologie, Hôpital Timone, Marseille, France
b Service de Chirurgie Cardiaque, Hôpital Timone, Marseille, France
c LERTIM, Faculté de Médecine de Marseille, Hôpital Timone, Marseille, France
d Fédération de Microbiologie, Hôpital Timone, Marseille, France
Accepted for publication June 15, 2007.
* Address correspondence to Dr Habib, La Timone Hospital, Cardiology, Blvd Jean Moulin, Marseille, 13005, France (Email: gilbert.habib{at}free.fr).
Background: Surgical treatment of active aortic infective endocarditis is challenging, and the type of prosthesis to be implanted during the active phase remains controversial.
Methods: All consecutive patients with definite diagnosis of aortic infective endocarditis operated on during the active phase were included. Endpoints were in-hospital mortality and a combined endpoint including infective endocarditis recurrence, prostheses dysfunction, or long-term cardiovascular mortality.
Results: Among 127 consecutive patients, mean age 57 ± 15 years, 87% male, 30% with preexisting aortic prosthesis, and 63 (50%) with annulus abscess, 54 (43%) were treated with aortic homograft and 73 (57%) with conventional prosthesis. Median time between diagnosis and surgery was 10 days. In-hospital mortality was 9%, not different between homograft and conventional prostheses (11% versus 8%, p[ = 0.6). By multivariable analysis, prosthetic valve endocarditis (8.5 95% confidence interval: 2.2 to 33.6, ]p = 0.001) was the only variable independently associated with in-hospital mortality, which was not influenced by type valvular substitute (p = 0.6), even in the subset with annulus abscess (p = 0.2). Ten-year survival free from the combined endpoint was 44% ± 10%, not different between homograft and conventional prostheses (log rank p = 0.2). By multivariable analysis, comorbidity index (2.6 [1.05 to 6.3], p = 0.04) and prosthetic valve endocarditis (2.3 [1.2 to 4.6], p = 0.02) were independently predictive of the combined endpoint, which was not determined by type of valvular substitute (p = 0.6) even in the subset with annulus abscess (p = 0.5).
Conclusions: Implantation of conventional prostheses during the active phase of aortic endocarditis yields similar low operative mortality and long-term prognosis as compared with aortic homografts, even in patients with annulus abscess.
Related Article
Ann. Thorac. Surg. 2007 84: 1942.
This article has been cited by other articles:
![]() |
P. M. Davierwala, C. Binner, K. Subramanian, M. Luehr, B. Pfannmueller, C. Etz, P. Dohmen, M. Misfeld, M. A. Borger, and F. W. Mohr Double valve replacement and reconstruction of the intervalvular fibrous body in patients with active infective endocarditis Eur J Cardiothorac Surg, May 3, 2013; (2013) ezt226v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Le Guillou, F. Bouchart, A. Gay, C. Nafeh-Bizet, C. Hubscher, A. Tabley, J. P. Bessou, and F. Doguet The Ross procedure in endocarditis: a report of 28 cases Eur J Cardiothorac Surg, April 26, 2013; (2013) ezt206v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, D. H. Adams, R. O. Bonow, N. T. Kouchoukos, D. C. Miller, P. T. O'Gara, D. M. Shahian, H. V. Schaff, C. W. Akins, J. Bavaria, et al. Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures: Executive Summary Ann. Thorac. Surg., April 1, 2013; 95(4): 1491 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jassar, J. E. Bavaria, W. Y. Szeto, P. J. Moeller, J. Maniaci, R. K. Milewski, J. H. Gorman III, N. D. Desai, R. C. Gorman, and A. Pochettino Graft Selection for Aortic Root Replacement in Complex Active Endocarditis: Does It Matter? Ann. Thorac. Surg., February 1, 2012; 93(2): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Prendergast and P. Tornos Surgery for Infective Endocarditis: Who and When? Circulation, March 9, 2010; 121(9): 1141 - 1152. [Full Text] [PDF] |
||||
![]() |
Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur. Heart J., October 1, 2009; 30(19): 2369 - 2413. [Full Text] [PDF] |
||||
![]() |
H. A. Cooper, E. C. Thompson, R. Laureno, A. Fuisz, A. S. Mark, M. Lin, and S. A. Goldstein Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study Circulation, August 18, 2009; 120(7): 585 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rekik, I. Trabelsi, I. Maaloul, M. Hentati, A. Hammami, I. Frikha, M. Ben Jemaa, and S. Kammoun Short- and long-term outcomes of surgery for active infective endocarditis: a Tunisian experience Interact CardioVasc Thorac Surg, August 1, 2009; 9(2): 241 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mihaljevic Invited commentary Ann. Thorac. Surg., December 1, 2007; 84(6): 1942 - 1942. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |